Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Q4 2021 Amneal Pharmaceuticals Inc Earnings Call Transcript

Mar 02, 2022 / 01:30PM GMT
Release Date Price: €3.96 (-1.00%)
Operator

Hello, and welcome to Amneal's Fourth Quarter and Full Year 2021 Earnings Call. My name is Alex, and I will be coordinating the call today. (Operator Instructions) I would like to turn the call over to Amneal's Head of Investor Relations, Tony DiMeo. Over to you, Tony.

Anthony DiMeo
Amneal Pharmaceuticals, Inc. - Senior Director of IR

Good morning, and thank you for joining Amneal's Fourth Quarter and Full Year 2021 Earnings Call. Today, we issued a press release reporting our financial results. The press release and presentation are available at amneal.com. We are conducting a live webcast of this call, a replay of which will be available on our website after the call.

Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Cautionary Statements on Forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot